Abstract

The Administration Core is the umbrella organization for the Program Project. Under the Direction of Dr. Stephan Targan, the Administration Core provides scientific guidance and disseminates current information regarding the field of inflammatory bowel diseases. The Program Project Manager provides fiscal and budgetary support as well as ensures that human subject and animal use protocols are current and compliant. The Administration Core interacts as liaison between the National Institutes of Health, Cedars-Sinai Medical Center, the University of California at Los Angeles, and the La Jolla Institute for Allergy and Immunology. The Administration Core organizes administrative/scientific meetings of the Program Project investigators. Logistical arrangements for the Scientific Advisory Committee and the organization of symposia are also provided. The Administration Core is the first source of contact with the Program Project advisors.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
2P01DK046763-24
Application #
9074359
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (J3)P)
Project Start
Project End
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
24
Fiscal Year
2016
Total Cost
$72,255
Indirect Cost
$25,401

  Institution

Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048

  Publications

Schwerd, T; Bryant, R V; Pandey, S et al. (2018) NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol 11:562-574
Herro, Rana; Shui, Jr-Wen; Zahner, Sonja et al. (2018) LIGHT-HVEM signaling in keratinocytes controls development of dermatitis. J Exp Med 215:415-422
Gu, Phillip; Kapur, Anshika; Li, Dalin et al. (2018) Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease. J Dig Dis 19:15-23
Schirmer, Melanie; Franzosa, Eric A; Lloyd-Price, Jason et al. (2018) Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol 3:337-346
Chang, Yu-Ling; Rossetti, Maura; Vlamakis, Hera et al. (2018) A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol :
Weiser, Matthew; Simon, Jeremy M; Kochar, Bharati et al. (2018) Molecular classification of Crohn's disease reveals two clinically relevant subtypes. Gut 67:36-42
Seo, Goo-Young; Shui, Jr-Wen; Takahashi, Daisuke et al. (2018) LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection. Cell Host Microbe 24:249-260.e4
Clerc, Florent; Novokmet, Mislav; Dotz, Viktoria et al. (2018) Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases. Gastroenterology 155:829-843
Rivas, Manuel A; Avila, Brandon E; Koskela, Jukka et al. (2018) Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population. PLoS Genet 14:e1007329
Hong, Myunghee; Ye, Byong Duk; Yang, Suk-Kyun et al. (2018) Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci. J Crohns Colitis 12:730-741

Showing the most recent 10 out of 277 publications